Sarcoidosis

DESTIN, Fla. — Complicated disease pathogenesis and a lack of FDA-approved therapies makes sarcoidosis a significant clinical challenge, according to a presenter at the 2023 Congress of Clinical Rheumatology-East.

A collection of new presenters will be speaking at the 2023 Congress of Clinical Rheumatology-East, covering biosimilars and complex diseases under the rheumatology umbrella, including sarcoidosis and Sjögren’s syndrome.

Patients with sarcoidosis of different races and sexes had differing frequencies of lung function impairment phenotypes, according to study results published in Annals of the American Thoracic Society.

NEW ORLEANS — Janus kinase inhibitors could be promising in the treatment of cutaneous sarcoidosis, which currently has no FDA-approved treatment options, according to a speaker here.

Twelve weeks of online mindfulness-based cognitive therapy better alleviated sarcoidosis-related fatigue than standard care, according to study results published in The Lancet Respiratory Medicine.

A higher BMI did not appear to increase risk for sarcoidosis, according to study results published in CHEST.

NASHVILLE, Tenn. — Patients who received immune checkpoint inhibitor therapy may have a greater risk for sarcoidosis, according to study results presented at CHEST Annual Meeting.

Although rare organ involvement with sarcoidosis may be indicative of more severe disease, it often does not require treatment, according to data published in Respiratory Medicine.

A 74-year-old white man presented as a referral to Lahey Hospital department of ophthalmology for a choroidal lesion of his left eye. He reported a progressive decline in his left eye vision for a year accompanied by intermittent floaters.

CLEVELAND — In this video from the Medical Dermatology Therapy Update II meeting, Joseph C. English III, MD, professor of dermatology at the University of Pittsburgh, gives an update on sarcoidosis and granulomatous diseases.